e-Article
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
Document Type
Article
Author
De Jaeghere, E.A.; Naert, E.; Denys, H.G.; Lippens, L.; Hendrix, A.; De Wever, O.; Van de Vijver, K.K.; Vandecasteele, K.; Tuyaerts, S.; Baiden-Amissah, R.; Amant, F.; Aspeslagh, S.; Van Nuffel, A.M.T.; Belmans, A.; Bogaerts, K.; Vuylsteke, P.; Henry, S.; Trinh, X.B.; van Dam, P.A.; De Caluwé, A.; Lambrechts, D.
Source
In: Cancer Immunology, Immunotherapy . (Cancer Immunology, Immunotherapy, February 2023, 72(2):475-491)
Subject
Language
English
ISSN
14320851
03407004
03407004